SPRY Therapeutics

About SPRY Therapeutics

SPRY Therapeutics, established in 2021 by Brijraj Bhuptani and Riyaz Rehman, operates as a SaaS provider for the physical therapy sector. Bhuptani, the former CTO of Ola, and Rehman were inspired to create the company after recognizing a significant technology gap in the physical therapy market, where practitioners were reliant on multiple, non-integrated tools. The founders, though not physical therapy specialists themselves, collaborated with U.S. insurance industry veterans and experienced physical therapists to develop their solution.

The company's core offering is an AI-driven, fully integrated practice management platform designed to serve physical therapists, occupational therapists, and speech-language pathologists. This platform consolidates all aspects of clinic management, from front-desk administrative tasks like scheduling and patient intake to clinical operations and back-office functions. A key focus is the automation of complex and operationally intensive billing processes, addressing major challenges for clinics such as insurance reimbursements and cash flow management. The platform, which includes the AI-powered tool suite "Spry Ally," aims to digitize the entire workflow, enhancing patient engagement and allowing therapists to spend more time on patient care.

SPRY Therapeutics generates revenue through its SaaS business model, providing its comprehensive platform at a single price point. The company targets the U.S. healthcare market, serving a range of clients from solo practitioners to larger, multi-location clinics. Since its launch, SPRY has shown significant market traction, partnering with over 105 clinics across 30 U.S. states within its first 18 months. The company's growth is backed by substantial venture capital funding, with a total of $25 million raised since its inception, including a $15 million round in October 2024. These funds are earmarked for accelerating the company's expansion in the United States.